Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

JP Morgan Upgrades Icon to Overweight, Raises Price Target to $320

JP Morgan analyst Tycho Peterson upgrades Icon (NASDAQ:ICLR) from Neutral to Overweight and raises the price target from $230 to $320.

byBenzinga Newsdesk

September 27, 2021

1 minute read

JP Morgan analyst Tycho Peterson upgrades Icon (NASDAQ:ICLR) from Neutral to Overweight and raises the price target from $230 to $320.

Morgan Stanley Maintains Overweight on State Street, Lowers Price Target to $86

By Benzinga Newsdesk

Today, 1:43 PM

Morgan Stanley analyst Betsy Graseck maintains State Street (NYSE:STT) with a Overweight and lowers the price target from $106 to $86.

STT

Analyst Ratings

8 Analysts Have This to Say About MKS Instruments

By Benzinga Insights

Today, 1:43 PM

Analysts have provided the following ratings for MKS Instruments (NASDAQ:MKSI) within the last quarter:

MKSI

Adaptive Biotechnologies Revises FY21 Sales Guidance From $145M-$155M To $148M-$155M vs $150.16M Est.

By Bill Haddad

Today, 1:43 PM

Adaptive Biotechnologies expects full year 2021 revenue to be in the range of $148 million to $155 million, representing 54% growth at the mid-point of the range over full year 2020 revenue. This compares to Adaptive

ADPT

Raymond James Maintains Outperform on Chevron, Raises Price Target to $173

By Benzinga Newsdesk

Today, 1:43 PM

Raymond James analyst Justin Jenkins maintains Chevron (NYSE:CVX) with a Outperform and raises the price target from $150 to $173.

CVX

JP Morgan Upgrades Icon to Overweight, Raises Price Target to $320

Related Posts

Morgan Stanley Maintains Overweight on State Street, Lowers Price Target to $86

8 Analysts Have This to Say About MKS Instruments

Adaptive Biotechnologies Revises FY21 Sales Guidance From $145M-$155M To $148M-$155M vs $150.16M Est.

Raymond James Maintains Outperform on Chevron, Raises Price Target to $173